- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fonar pursues legal battle with MR Plus
Score another legal victory for Fonar. On March 21, the Melville, NY-based company announced that the $2.3 million judgment rendered against Fonar for independent service provider Magnetic Resonance Plus has been set aside. In its decision, the U.S.
Score another legal victory for Fonar. On March 21, the Melville, NY-based company announced that the $2.3 million judgment rendered against Fonar for independent service provider Magnetic Resonance Plus has been set aside. In its decision, the U.S. District Court for the southern district of New York also ordered a new trial, according to Fonar.
In December, a federal jury had awarded MR Plus $2.3 million, but the verdict was later overturned by the appeals court in January, which also reinstated Fonar's copyright-infringement and unfair-competition claims (SCAN 3/5/97).
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
